MedTrace Logo

Colvera for Detection of Disease Recurrence

NCT03706235 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 488

Last updated 2020-07-14

No results posted yet for this study

Summary

To compare the sensitivity and specificity estimates of Colvera with that of a commercially available CEA test for detection of recurrent disease in CRC subjects who are undergoing surveillance for recurrence.

Conditions

  • Colorectal Adenocarcinoma

Interventions

OTHER

Blood draw (venipuncture)

Draw 40 mls of blood from eligible subjects. Process and ship samples to sponsor.

Sponsors & Collaborators

  • Clinical Genomics Pathology

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-02-01
Primary Completion
2019-08-16
Completion
2020-04-29

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03706235 on ClinicalTrials.gov